Neurogene Inc.

Neurogene Inc.verified

NGNE

Price:

$21.16

Market Cap:

$327.75M

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.

Industry

Biotechnology

IPO Date

2014-03-07

Stock Exchange

NASDAQ

Ticker

NGNE

The PE Ratio as of December 2025 (TTM) for Neurogene Inc. (NGNE) is -5.16

According to Neurogene Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.16. This represents a change of 37.45% compared to the average of -3.75 of the last 4 quarters.

Neurogene Inc. (NGNE) Historical PE Ratio (quarterly & annually)

How has NGNE PE Ratio performed in the past?

The mean historical PE Ratio of Neurogene Inc. over the last ten years is -110.97. The current -5.16 PE Ratio has changed 365.01% with respect to the historical average. Over the past ten years (40 quarters), NGNE's PE Ratio was at its highest in in the June 2018 quarter at 106.81. The PE Ratio was at its lowest in in the June 2019 quarter at -274210.34.

Quarterly (TTM)
Annual

Average

-110.97

Median

-100.47

Minimum

-439.18

Maximum

-2.37

Neurogene Inc. (NGNE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Neurogene Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 357.90%

Maximum Annual PE Ratio = -2.37

Minimum Annual Increase = -97.75%

Minimum Annual PE Ratio = -439.18

Quarterly (TTM)
Annual
YearPE RatioChange
2024-5.34-21.90%
2023-6.84189.30%
2022-2.37-97.75%
2021-105.03-76.08%
2020-439.18357.90%
2019-95.91198.15%
2018-32.17-70.73%
2017-109.91-34.81%
2016-168.6016.84%
2015-144.30164.39%

Neurogene Inc. (NGNE) Average PE Ratio

How has NGNE PE Ratio performed in the past?

The current PE Ratio of Neurogene Inc. (NGNE) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.85

5-year avg

-111.75

10-year avg

-110.97

Neurogene Inc. (NGNE) PE Ratio vs. Peers

How is NGNE’s PE Ratio compared to its peers?

Neurogene Inc.’s PE Ratio is greater than Lineage Cell Therapeutics, Inc. (-5.89), greater than Ocugen, Inc. (-6.36), greater than Fulcrum Therapeutics, Inc. (-7.71), less than Autolus Therapeutics plc (-1.83), less than ADC Therapeutics S.A. (-2.89), greater than Benitec Biopharma Inc. (-13.08), less than Solid Biosciences Inc. (-3.34), less than PureTech Health plc (7.62), less than Quantum-Si incorporated (-2.54), less than Alumis Inc. Common Stock (-3.52),

Build a custom stock screener for Neurogene Inc. (NGNE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurogene Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neurogene Inc. (NGNE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neurogene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Neurogene Inc.'s PE Ratio?

How is the PE Ratio calculated for Neurogene Inc. (NGNE)?

What is the highest PE Ratio for Neurogene Inc. (NGNE)?

What is the 3-year average PE Ratio for Neurogene Inc. (NGNE)?

What is the 5-year average PE Ratio for Neurogene Inc. (NGNE)?

How does the current PE Ratio for Neurogene Inc. (NGNE) compare to its historical average?